Fighting cancer with next generation armed cell and gene therapies

News & Press Releases

November 14, 2023
Regulatory Press Release
Press Release
Elicera Therapeutics AB (publ) Interim Report January 1 – September 30, 2023
Read more
October 31, 2023
Regulatory Press Release
Press Release
Nomination Committee for Elicera therapeutics appointed
Read more
All news
Harnessing the patient’s immune system to fight cancer
Read more
A universal CAR T-cell enhancement technology platform
Read more
The company’s product portfolio consists of four drug candidates
Read more

Get to know Elicera Therapeutics

Elicera's strengths are based on a deep understanding of how cells and viruses can be genetically engineered to trigger a powerful immune response to cancer.

Di Yu, Head of Technical Operations and co-founder, tells more about Elicera in the film.

About Elicera

iTANK-technology platform

A universal CAR T-cell technology platform, compatible with any CAR T-cell therapy for a multi-targeted attack on solid tumors.

Upcoming events and presentations

December 5, 2023
ATMP Sweden 2023
Read more (external link)
All Events and Presentations
Watch our latest company presentation

Sign up for Press Releases

By filling out the form you are approving that Elicera stores your information. Read more about our integrity policy here.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.